Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | CKAP2 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CKAP2 mRNA | CTD | PMID:36331819 | CKAP2 | Human | 1,1-dichloroethene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | vinylidene chloride results in increased expression of CKAP2 mRNA | CTD | PMID:26682919 | CKAP2 | Human | 1-naphthyl isothiocyanate | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of CKAP2 mRNA | CTD | PMID:30723492 | CKAP2 | Human | 17beta-estradiol | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | ESR1 protein promotes the reaction [Estradiol results in increased expression of CKAP2 mRNA] | CTD | PMID:25210133 | CKAP2 | Human | 17beta-estradiol | affects expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Estradiol affects the expression of CKAP2 mRNA | CTD | PMID:32145629 | CKAP2 | Human | 17beta-estradiol | multiple interactions | ISO | Ckap2 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA | CTD | PMID:32741896 | CKAP2 | Human | 17beta-estradiol | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Estradiol results in increased expression of CKAP2 mRNA | CTD | PMID:25210133 | CKAP2 | Human | 17beta-estradiol 3-benzoate | multiple interactions | ISO | Ckap2 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA | CTD | PMID:32741896 | CKAP2 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CKAP2 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CKAP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CKAP2 mRNA | CTD | PMID:19770486 | CKAP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CKAP2 mRNA | CTD | PMID:32109520 and PMID:34747641 | CKAP2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ckap2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CKAP2 mRNA | CTD | PMID:26377647 | CKAP2 | Human | 2,4-diaminotoluene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | 2 and 4-diaminotoluene results in increased expression of CKAP2 mRNA | CTD | PMID:20713471 | CKAP2 | Human | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Ckap2 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | CKAP2 | Human | 2-amino-2-deoxy-D-glucopyranose | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Glucosamine results in decreased expression of CKAP2 mRNA | CTD | PMID:17109745 | CKAP2 | Human | 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of CKAP2 mRNA | CTD | PMID:21179406 | CKAP2 | Human | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of CKAP2 mRNA | CTD | PMID:37199045 | CKAP2 | Human | 3-methylcholanthrene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of CKAP2 mRNA | CTD | PMID:20713471 | CKAP2 | Human | 4-hydroxyphenyl retinamide | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Fenretinide results in increased expression of CKAP2 mRNA | CTD | PMID:28973697 | CKAP2 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of CKAP2 mRNA | CTD | PMID:24780913 | CKAP2 | Human | 7,12-dimethyltetraphene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | 9 more ... | CTD | PMID:32553695 | CKAP2 | Human | acetamide | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CKAP2 mRNA | CTD | PMID:31881176 | CKAP2 | Human | acrylamide | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of CKAP2 mRNA | CTD | PMID:28959563 | CKAP2 | Human | aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of CKAP2 protein | CTD | PMID:20106945 | CKAP2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of CKAP2 exon | CTD | PMID:30157460 | CKAP2 | Human | aflatoxin B1 | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of CKAP2 mRNA | CTD | PMID:23630614 more ... | CKAP2 | Human | Aflatoxin B2 alpha | decreases methylation | EXP | | 6480464 | aflatoxin B2 results in decreased methylation of CKAP2 exon | CTD | PMID:30157460 | CKAP2 | Human | aldehydo-D-glucosamine | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Glucosamine results in decreased expression of CKAP2 mRNA | CTD | PMID:17109745 | CKAP2 | Human | aldehydo-D-glucose | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA | CTD | PMID:37567420 | CKAP2 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of CKAP2 mRNA | CTD | PMID:33167477 | CKAP2 | Human | antirheumatic drug | decreases expression | EXP | | 6480464 | Antirheumatic Agents results in decreased expression of CKAP2 mRNA | CTD | PMID:24449571 | CKAP2 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of CKAP2 protein | CTD | PMID:33212167 | CKAP2 | Human | arsenous acid | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of CKAP2 mRNA | CTD | PMID:29095437 | CKAP2 | Human | arsenous acid | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] | CTD | PMID:29095437 | CKAP2 | Human | azathioprine | decreases expression | EXP | | 6480464 | Azathioprine results in decreased expression of CKAP2 mRNA | CTD | PMID:22623647 | CKAP2 | Human | benzo[a]pyrene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Benzo(a)pyrene metabolite results in increased expression of CKAP2 mRNA and Benzo(a)pyrene results in increased expression of CKAP2 mRNA | CTD | PMID:19770486 more ... | CKAP2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of CKAP2 exon | CTD | PMID:30157460 | CKAP2 | Human | benzo[a]pyrene | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA | CTD | PMID:27858113 | CKAP2 | Human | benzo[a]pyrene diol epoxide I | decreases expression | EXP | | 6480464 | 7 more ... | CTD | PMID:20382639 | CKAP2 | Human | benzo[b]fluoranthene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in increased expression of CKAP2 mRNA | CTD | PMID:26377693 | CKAP2 | Human | benzo[b]fluoranthene | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA | CTD | PMID:27858113 | CKAP2 | Human | benzo[e]pyrene | decreases methylation | EXP | | 6480464 | benzo(e)pyrene results in decreased methylation of CKAP2 exon | CTD | PMID:30157460 | CKAP2 | Human | beta-D-glucosamine | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Glucosamine results in decreased expression of CKAP2 mRNA | CTD | PMID:17109745 | CKAP2 | Human | beta-lapachone | decreases expression | EXP | | 6480464 | beta-lapachone results in decreased expression of CKAP2 mRNA | CTD | PMID:38218311 | CKAP2 | Human | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of CKAP2 mRNA | CTD | PMID:19490990 | CKAP2 | Human | bisphenol A | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of CKAP2 mRNA | CTD | PMID:32145629 and PMID:34947998 | CKAP2 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CKAP2 mRNA | CTD | PMID:29275510 | CKAP2 | Human | bisphenol A | increases methylation | ISO | Ckap2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of CKAP2 gene | CTD | PMID:28505145 | CKAP2 | Human | bisphenol A | affects expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CKAP2 mRNA | CTD | PMID:25181051 | CKAP2 | Human | buta-1,3-diene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | 1 and 3-butadiene results in increased expression of CKAP2 mRNA | CTD | PMID:29038090 | CKAP2 | Human | cadmium dichloride | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased expression of CKAP2 mRNA | CTD | PMID:25993096 | CKAP2 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CKAP2 mRNA | CTD | PMID:38568856 | CKAP2 | Human | caffeine | decreases phosphorylation | EXP | | 6480464 | Caffeine results in decreased phosphorylation of CKAP2 protein | CTD | PMID:35688186 | CKAP2 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of CKAP2 mRNA | CTD | PMID:21592394 | CKAP2 | Human | calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CKAP2 mRNA | CTD | PMID:21592394 | CKAP2 | Human | carbon nanotube | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25926378 | CKAP2 | Human | cefaloridine | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Cephaloridine results in decreased expression of CKAP2 mRNA | CTD | PMID:18500788 | CKAP2 | Human | choline | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CKAP2 mRNA | CTD | PMID:20938992 | CKAP2 | Human | chrysene | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA | CTD | PMID:27858113 | CKAP2 | Human | cisplatin | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Cisplatin results in increased expression of CKAP2 mRNA | CTD | PMID:21151649 | CKAP2 | Human | clofibrate | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA] | CTD | PMID:17585979 | CKAP2 | Human | copper atom | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Copper results in increased expression of CKAP2 mRNA | CTD | PMID:30556269 | CKAP2 | Human | copper(0) | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Copper results in increased expression of CKAP2 mRNA | CTD | PMID:30556269 | CKAP2 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of CKAP2 mRNA | CTD | PMID:19549813 | CKAP2 | Human | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CKAP2 mRNA | CTD | PMID:19167446 | CKAP2 | Human | CU-O LINKAGE | decreases expression | EXP | | 6480464 | cupric oxide results in decreased expression of CKAP2 mRNA | CTD | PMID:22077320 | CKAP2 | Human | Cuprizon | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of CKAP2 mRNA | CTD | PMID:26577399 and PMID:27523638 | CKAP2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CKAP2 mRNA | CTD | PMID:20106945 more ... | CKAP2 | Human | D-glucose | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA | CTD | PMID:37567420 | CKAP2 | Human | deoxynivalenol | increases expression | EXP | | 6480464 | deoxynivalenol results in increased expression of CKAP2 mRNA | CTD | PMID:31863870 | CKAP2 | Human | diallyl trisulfide | decreases expression | EXP | | 6480464 | diallyl trisulfide results in decreased expression of CKAP2 mRNA | CTD | PMID:34995734 | CKAP2 | Human | diarsenic trioxide | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Arsenic Trioxide results in increased expression of CKAP2 mRNA | CTD | PMID:29095437 | CKAP2 | Human | diarsenic trioxide | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] | CTD | PMID:29095437 | CKAP2 | Human | dibenz[a,h]anthracene | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | CKAP2 | Human | dibutyl phthalate | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of CKAP2 mRNA | CTD | PMID:17361019 and PMID:21266533 | CKAP2 | Human | dichloroacetic acid | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of CKAP2 mRNA | CTD | PMID:28962523 | CKAP2 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of CKAP2 mRNA | CTD | PMID:28302478 | CKAP2 | Human | dioxygen | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CKAP2 mRNA | CTD | PMID:30529165 | CKAP2 | Human | diquat | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Diquat results in decreased expression of CKAP2 mRNA | CTD | PMID:36851058 | CKAP2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CKAP2 | Human | doxorubicin | affects response to substance | EXP | | 6480464 | CKAP2 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | CKAP2 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of CKAP2 mRNA | CTD | PMID:29803840 | CKAP2 | Human | Echimidine | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | echimidine results in increased expression of CKAP2 mRNA | CTD | PMID:32419051 | CKAP2 | Human | elemental selenium | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of CKAP2 mRNA | CTD | PMID:19244175 | CKAP2 | Human | endosulfan | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of CKAP2 mRNA | CTD | PMID:29391264 | CKAP2 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of CKAP2 protein | CTD | PMID:23301498 | CKAP2 | Human | ethyl methanesulfonate | increases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in increased expression of CKAP2 mRNA | CTD | PMID:23649840 | CKAP2 | Human | flutamide | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Flutamide results in increased expression of CKAP2 mRNA | CTD | PMID:24793618 | CKAP2 | Human | folic acid | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CKAP2 mRNA | CTD | PMID:20938992 | CKAP2 | Human | FR900359 | increases phosphorylation | EXP | | 6480464 | FR900359 results in increased phosphorylation of CKAP2 protein | CTD | PMID:37730182 | CKAP2 | Human | fructose | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA | CTD | PMID:37567420 | CKAP2 | Human | furan | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | furan results in increased expression of CKAP2 mRNA | CTD | PMID:25539665 | CKAP2 | Human | gentamycin | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CKAP2 mRNA | CTD | PMID:33387578 | CKAP2 | Human | glucose | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA | CTD | PMID:37567420 | CKAP2 | Human | glycidol | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | glycidol results in decreased expression of CKAP2 mRNA | CTD | PMID:24395379 and PMID:24915197 | CKAP2 | Human | glyphosate | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of CKAP2 mRNA | CTD | PMID:37567420 | CKAP2 | Human | Heliotrine | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | heliotrine results in increased expression of CKAP2 mRNA | CTD | PMID:32419051 | CKAP2 | Human | hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of CKAP2 mRNA | CTD | PMID:21179406 | CKAP2 | Human | L-methionine | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CKAP2 mRNA | CTD | PMID:20938992 | CKAP2 | Human | leflunomide | decreases expression | EXP | | 6480464 | leflunomide results in decreased expression of CKAP2 mRNA | CTD | PMID:28988120 | CKAP2 | Human | lidocaine | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of CKAP2 mRNA | CTD | PMID:35283115 | CKAP2 | Human | metformin | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | Metformin inhibits the reaction [Arsenic Trioxide results in increased expression of CKAP2 mRNA] | CTD | PMID:29095437 | CKAP2 | Human | methamphetamine | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Methamphetamine results in decreased expression of CKAP2 mRNA | CTD | PMID:28341135 | CKAP2 | Human | methapyrilene | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Methapyrilene results in increased expression of CKAP2 mRNA | CTD | PMID:30467583 | CKAP2 | Human | methapyrilene | decreases methylation | EXP | | 6480464 | Methapyrilene results in decreased methylation of CKAP2 exon | CTD | PMID:30157460 | CKAP2 | Human | methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of CKAP2 mRNA | CTD | PMID:23649840 | CKAP2 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of CKAP2 mRNA | CTD | PMID:28001369 | CKAP2 | Human | mitomycin C | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Mitomycin results in increased expression of CKAP2 mRNA | CTD | PMID:25270620 | CKAP2 | Human | N-nitrosodiethylamine | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CKAP2 mRNA and RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CKAP2 mRNA] | CTD | PMID:17854601 and PMID:24535843 | CKAP2 | Human | N-nitrosodiethylamine | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of CKAP2 mRNA | CTD | PMID:17854601 and PMID:24535843 | CKAP2 | Human | oxaliplatin | multiple interactions | ISO | Ckap2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CKAP2 mRNA | CTD | PMID:25729387 | CKAP2 | Human | ozone | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Ozone results in decreased expression of CKAP2 mRNA | CTD | PMID:24336422 | CKAP2 | Human | ozone | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CKAP2 mRNA more ... | CTD | PMID:25658374 more ... | CKAP2 | Human | paracetamol | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of CKAP2 mRNA] | CTD | PMID:17585979 | CKAP2 | Human | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CKAP2 mRNA | CTD | PMID:22230336 | CKAP2 | Human | PCB138 | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | CKAP2 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CKAP2 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CKAP2 mRNA | CTD | PMID:36331819 | CKAP2 | Human | phenformin | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Phenformin results in decreased expression of CKAP2 mRNA | CTD | PMID:31324951 | CKAP2 | Human | phenobarbital | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CKAP2 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CKAP2 mRNA] | CTD | PMID:19482888 and PMID:24535843 | CKAP2 | Human | phenobarbital | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Phenobarbital results in increased expression of CKAP2 mRNA | CTD | PMID:19482888 and PMID:23091169 | CKAP2 | Human | phenylmercury acetate | decreases expression | EXP | | 6480464 | Phenylmercuric Acetate results in decreased expression of CKAP2 mRNA | CTD | PMID:26272509 | CKAP2 | Human | phenylmercury acetate | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CKAP2 mRNA | CTD | PMID:27188386 | CKAP2 | Human | PhIP | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4 and 5-b)pyridine results in increased expression of CKAP2 mRNA | CTD | PMID:29877212 | CKAP2 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CKAP2 mRNA | CTD | PMID:19710929 | CKAP2 | Human | pirinixic acid | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | pirinixic acid results in increased expression of CKAP2 mRNA | CTD | PMID:18301758 and PMID:23811191 | CKAP2 | Human | pirinixic acid | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CKAP2 mRNA | CTD | PMID:20813756 | CKAP2 | Human | progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of CKAP2 mRNA | CTD | PMID:21795739 | CKAP2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with Resveratrol] results in increased expression of CKAP2 mRNA and [Plant Extracts co-treated with Resveratrol] results in increased expression of CKAP2 mRNA | CTD | PMID:19167446 and PMID:23557933 | CKAP2 | Human | rotenone | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Rotenone results in decreased expression of CKAP2 mRNA | CTD | PMID:28374803 | CKAP2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | CKAP2 | Human | selenium atom | decreases expression | EXP | | 6480464 | Selenium results in decreased expression of CKAP2 mRNA | CTD | PMID:19244175 | CKAP2 | Human | senecionine | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | senecionine results in increased expression of CKAP2 mRNA | CTD | PMID:32419051 | CKAP2 | Human | Senkirkine | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | senkirkine results in increased expression of CKAP2 mRNA | CTD | PMID:32419051 | CKAP2 | Human | serpentine asbestos | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | SPP1 gene mutant form inhibits the reaction [Asbestos and Serpentine results in increased expression of CKAP2 mRNA] | CTD | PMID:21514415 | CKAP2 | Human | serpentine asbestos | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Asbestos and Serpentine results in increased expression of CKAP2 mRNA | CTD | PMID:21514415 | CKAP2 | Human | silicon dioxide | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Silicon Dioxide results in increased expression of CKAP2 mRNA | CTD | PMID:29341224 | CKAP2 | Human | silver atom | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Silver results in decreased expression of CKAP2 mRNA | CTD | PMID:27131904 | CKAP2 | Human | silver(0) | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Silver results in decreased expression of CKAP2 mRNA | CTD | PMID:27131904 | CKAP2 | Human | sodium arsenite | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CKAP2 mRNA | CTD | PMID:17998272 | CKAP2 | Human | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of CKAP2 mRNA | CTD | PMID:29301061 | CKAP2 | Human | sodium dichromate | affects expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | sodium bichromate affects the expression of CKAP2 mRNA | CTD | PMID:22110744 | CKAP2 | Human | sodium fluoride | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Sodium Fluoride results in decreased expression of CKAP2 protein | CTD | PMID:28918527 | CKAP2 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of CKAP2 mRNA | CTD | PMID:31533062 | CKAP2 | Human | tacrolimus hydrate | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Tacrolimus results in increased expression of CKAP2 mRNA | CTD | PMID:29362864 | CKAP2 | Human | testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CKAP2 mRNA | CTD | PMID:21592394 | CKAP2 | Human | testosterone | multiple interactions | ISO | Ckap2 (Rattus norvegicus) | 6480464 | [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CKAP2 mRNA | CTD | PMID:32741896 | CKAP2 | Human | testosterone | decreases expression | EXP | | 6480464 | Testosterone results in decreased expression of CKAP2 mRNA | CTD | PMID:21592394 | CKAP2 | Human | testosterone enanthate | affects expression | EXP | | 6480464 | testosterone enanthate affects the expression of CKAP2 mRNA | CTD | PMID:17440010 | CKAP2 | Human | tetrachloromethane | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CKAP2 mRNA | CTD | PMID:17484886 more ... | CKAP2 | Human | tetraphene | multiple interactions | ISO | Ckap2 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of CKAP2 mRNA | CTD | PMID:27858113 | CKAP2 | Human | thioacetamide | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CKAP2 mRNA | CTD | PMID:23411599 and PMID:34492290 | CKAP2 | Human | thiram | decreases expression | EXP | | 6480464 | Thiram results in decreased expression of CKAP2 mRNA | CTD | PMID:38568856 | CKAP2 | Human | titanium dioxide | increases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | titanium dioxide results in increased expression of CKAP2 mRNA | CTD | PMID:30012374 | CKAP2 | Human | topotecan | decreases expression | ISO | Ckap2 (Rattus norvegicus) | 6480464 | Topotecan results in decreased expression of CKAP2 mRNA | CTD | PMID:25729387 | CKAP2 | Human | topotecan | multiple interactions | ISO | Ckap2 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of CKAP2 mRNA | CTD | PMID:25729387 | CKAP2 | Human | topotecan | affects response to substance | EXP | | 6480464 | CKAP2 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | CKAP2 | Human | trimellitic anhydride | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of CKAP2 mRNA | CTD | PMID:19042947 | CKAP2 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of CKAP2 mRNA | CTD | PMID:37042841 | CKAP2 | Human | Triptolide | increases expression | ISO | Ckap2 (Mus musculus) | 6480464 | triptolide results in increased expression of CKAP2 mRNA | CTD | PMID:32835833 | CKAP2 | Human | trovafloxacin | decreases expression | ISO | Ckap2 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of CKAP2 mRNA | CTD | PMID:35537566 | CKAP2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of CKAP2 mRNA | CTD | PMID:23179753 more ... | CKAP2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CKAP2 mRNA | CTD | PMID:27188386 | CKAP2 | Human | vincaleukoblastine | affects response to substance | EXP | | 6480464 | CKAP2 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | CKAP2 | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of CKAP2 mRNA | CTD | PMID:19244175 | |